Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.23 - $0.46 $24,678 - $49,356
-107,296 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$0.3 - $0.61 $2,265 - $4,606
-7,552 Reduced 6.58%
107,296 $46,000
Q4 2021

Feb 11, 2022

SELL
$0.55 - $1.04 $1,889 - $3,573
-3,436 Reduced 2.9%
114,848 $63,000
Q3 2021

Nov 12, 2021

SELL
$1.06 - $1.52 $2,979 - $4,272
-2,811 Reduced 2.32%
118,284 $125,000
Q2 2021

Aug 13, 2021

SELL
$1.22 - $1.65 $4,457 - $6,029
-3,654 Reduced 2.93%
121,095 $183,000
Q1 2021

May 07, 2021

BUY
$1.18 - $2.62 $23,643 - $52,496
20,037 Added 19.14%
124,749 $192,000
Q4 2020

Feb 12, 2021

BUY
$1.05 - $2.24 $73,724 - $157,279
70,214 Added 203.53%
104,712 $110,000
Q3 2020

Nov 04, 2020

BUY
$1.7 - $6.41 $8,678 - $32,723
5,105 Added 17.37%
34,498 $70,000
Q2 2020

Aug 12, 2020

BUY
$0.87 - $2.46 $25,571 - $72,306
29,393 New
29,393 $65,000

About iBio, Inc.


  • Ticker IBIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,006,580
  • Market Cap $24M
  • Description
  • iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...
More about IBIO
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.